No Photo Available

Last Update

This profile was last updated on .

Is this you? Claim your profile.

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Company Description

Langford IC Systems, Inc.'s mission is to utilize advanced technology to provide the Healthcare Industry with affordable, easy to operate, cleaner-processors that safely and effectively reprocess medical devices, instruments, and implantable(s). Langford ... more

Find other employees at this company (3)

Background Information

Employment History

Executive Vice President

Merck & Co. , Inc.

Affiliations

Board Member
MD EDGE , Inc.

Board Member
Alpharma Inc.

Board Member
IntraBiotics Pharmaceuticals , Inc.

Board Member
Alexion Pharmaceuticals Inc

Board Member
COR Therapeutics , Inc.

Board Member
ALZA Corporation

Education

MD EDGE , Inc.

bachelor of arts degree

University of New Mexico

Web References (65 Total References)


def14a

www.sec.gov [cached]

Jerry T. Jackson

...
Jerry T. Jackson.Mr. Jackson has served as a Director since September 2002.Mr. Jackson was employed by Merck & Co., Inc., a pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until retirement, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups, including being President of Merck's Worldwide Human Health Division in 1993.Mr. Jackson was Senior Vice President responsible for Merck's Specialty Chemicals Business from 1991 to 1992.Previously, he was President of Merck's International Division from 1988 to 1991.Mr. Jackson has served on the board of directors of several biotech pharmaceutical companies and currently is on the Board of Directors of Langford I.C. Systems Inc., a privately-held company.Mr. Jackson holds a B.A. in education from the University of New Mexico.


Jerry T. Jackson ...

www.sec.gov [cached]

Jerry T. Jackson (2)(3)

...
Jerry T. Jackson has been a director of Alexion since September 1999.He was employed by Merck & Co.Inc., a major pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until 1995, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups including Merck's International Human Health, Worldwide Human Vaccines, the AgVet Division, Astra/Merck U.S. Operations, as well as worldwide marketing.During 1993, he was also President of the Worldwide Human Health Division.He served as Senior Vice President of Merck from 1991 to 1992 responsible for Merck's Specialty Chemicals and previously, he was President of Merck's Sharp & Dohme International.Mr. Jackson serves as a director of Langford I.C. Systems, Inc., IntraBiotics Pharmaceuticals, Inc., and Myogen, Inc., each a small pharmaceutical company.He received his B.A. from University of New Mexico.


Mr. Mark Perry, Dr. Jack Remington, ...

www.sec.gov [cached]

Mr. Mark Perry, Dr. Jack Remington, Mr. Jerry Jackson and Mr. Gary Lyons are independent directors under applicable SEC and Nasdaq rules.

...
Jerry T. Jackson, age 62, has served as a director of IntraBiotics since August 2002.Mr. Jackson is currently and has been retired since 1995.Mr. Jackson was employed by Merck , Co., Inc., a major pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until retirement, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups, including being President of Merck's Worldwide Human Health Division in 1993 and Senior Vice President responsible for Merck's Specialty Chemicals Business from 1991 to 1992.Previously, he was President of Merck's International Division.Mr. Jackson has served on the board of directors of several biotech pharmaceutical companies and currently serves as a director of Alexion Pharmaceuticals, Inc., Myogen, Inc. and Langford I.C. Systems, Inc.Mr. Jackson received a B.A. degree in Education from the University of New Mexico in 1964.
...
Three directors comprise the Audit Committee: Mr. Perry, who was elected to the committee in September 2003, Mr. Lyons and Mr. Jackson.
...
Three directors comprise the Compensation Committee: Mr. Lyons, Mr. Perry, who was elected to the Compensation Committee in November 2003, and Mr. Jackson, who was elected to the committee in September 2003.
...
IntraBiotics' Compensation Committee currently consists of Mr. Lyons, Mr. Perry and Mr. Jackson.
...
Three directors comprise the Nominating and Corporate Governance Committee: Dr. Mario, Mr. Jackson and Mr. Perry.


Mr. Mark Perry, Dr. Jack Remington, ...

www.sec.gov [cached]

Mr. Mark Perry, Dr. Jack Remington, Mr. Jerry Jackson and Mr. Gary Lyons are independent directors under applicable SEC and Nasdaq rules.

...
Jerry T. Jackson, age 62, has served as a director of IntraBiotics since August 2002.Mr. Jackson is currently and has been retired since 1995.Mr. Jackson was employed by Merck , Co., Inc., a major pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until retirement, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups, including being President of Merck's Worldwide Human Health Division in 1993 and Senior Vice President responsible for Merck's Specialty Chemicals Business from 1991 to 1992.Previously, he was President of Merck's International Division.Mr. Jackson has served on the board of directors of several biotech pharmaceutical companies and currently serves as a director of Alexion Pharmaceuticals, Inc., Myogen, Inc. and Langford I.C. Systems, Inc.Mr. Jackson received a B.A. degree in Education from the University of New Mexico in 1964.
...
Three directors comprise the Audit Committee: Mr. Perry, who was elected to the committee in September 2003, Mr. Lyons and Mr. Jackson.
...
Three directors comprise the Compensation Committee: Mr. Lyons, Mr. Perry, who was elected to the Compensation Committee in November 2003, and Mr. Jackson, who was elected to the committee in September 2003.
...
IntraBiotics' Compensation Committee currently consists of Mr. Lyons, Mr. Perry and Mr. Jackson.
...
Three directors comprise the Nominating and Corporate Governance Committee: Dr. Mario, Mr. Jackson and Mr. Perry.


Mr. Mark Perry, Dr. Jack Remington, ...

www.sec.gov [cached]

Mr. Mark Perry, Dr. Jack Remington, Mr. Jerry Jackson and Mr. Gary Lyons are independent directors under applicable SEC and Nasdaq rules.

...
Jerry T. Jackson, age 62, has served as a director of IntraBiotics since August 2002.Mr. Jackson is currently and has been retired since 1995.Mr. Jackson was employed by Merck , Co., Inc., a major pharmaceutical company, from 1965 until his retirement in 1995.During this time, he had extensive experience in sales, marketing and corporate management, including joint ventures.From 1993 until retirement, Mr. Jackson served as Executive Vice President of Merck with broad responsibilities for numerous operating groups, including being President of Merck's Worldwide Human Health Division in 1993 and Senior Vice President responsible for Merck's Specialty Chemicals Business from 1991 to 1992.Previously, he was President of Merck's International Division.Mr. Jackson has served on the board of directors of several biotech pharmaceutical companies and currently serves as a director of Alexion Pharmaceuticals, Inc., Myogen, Inc. and Langford I.C. Systems, Inc.Mr. Jackson received a B.A. degree in Education from the University of New Mexico in 1964.
...
Three directors comprise the Audit Committee: Mr. Perry, who was elected to the committee in September 2003, Mr. Lyons and Mr. Jackson.
...
Three directors comprise the Compensation Committee: Mr. Lyons, Mr. Perry, who was elected to the Compensation Committee in November 2003, and Mr. Jackson, who was elected to the committee in September 2003.
...
IntraBiotics' Compensation Committee currently consists of Mr. Lyons, Mr. Perry and Mr. Jackson.
...
Three directors comprise the Nominating and Corporate Governance Committee: Dr. Mario, Mr. Jackson and Mr. Perry.

Similar Profiles

Other People with this Name

Other people with the name Jackson

Sandy Jackson
Pirate Homes & Realty

Andrew Jackson
Mackay Group

Brenda Jackson

Margaret Jackson
Allied Express

Tim Jackson
Access 4 Pty Ltd

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory